We can expect that patients with different types of diabetes might be under different risk for cardiovascular disease, in part because of a period of undiagnosed type 2 diabetes but mostly because of the difference in inflammation, adiponectin level, and presentation of metabolic syndrome in each type of diabetes. This evidence concerns the gene ADIPOQ and metabolic syndrome.